Clinical Trials · NCT02084654
Exenatide and Weight Loss for Diabetes Prevention
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Stanford University
- Enrollment
- 66
- Start date
- Nov 2007
- Locations
- See registry
- Primary endpoint
- First-phase insulin response